Efficacy and safety of once-weekly semaglutide versus once-daily insulin glargine as add-on to metformin (with or without sulfonylureas) in insulin-naive patients with type 2 diabetes (SUSTAIN 4): A randomised, open-label, parallel-group, multicentre, multinational, phase 3a trial
The market is expected to grow at a CAGR of 25.96% from 2025 to 2034 North America dominated the wegovy market with the largest share of 48% in 2024
was a 56-week randomized, double-blind, placebo-controlled trial designed to assess the efficacy and safety of liraglutide 3.0 mg for weight management in adults without type 2 diabetes [21]
Patients should review all their medications with their healthcare provider, as concomitant medicines (including SGLT2 inhibitors, diuretics, or caffeine-containing products) may contribute to increased urination
It may be time to discuss surgical body contouring when loose skin: Interferes with clothing fit or comfort Creates folds that are difficult to manage with hygiene or skin care Makes exercise or movement uncomfortable Causes the body shape to feel out of proportion after weight loss Remains despite strength training, stable nutrition, and time for the body to adjust Affects the face, neck, arms, abdomen, breasts, thighs, back, or buttocks in a way the patient wants evaluated A surgical consultation is not a commitment to surgery
& Mirza, M
